FABP5P14

Across TCGA pan-cancer cohorts, FABP5P14 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of FABP5P14’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where FABP5P14 RNA is repressed in tumor relative to normal tissue. In most cancer types FABP5P14 is over-expressed in tumor, although a few such as KIRC and THCA show the opposite, repressed pattern.

KIRC, THCA, and LUSC are the cancer types where FABP5P14 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FABP5P14 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	−0.076	<.001	8	view →
THCA	All	All	−0.169	<.001	5	view →
LUSC	Male	All	−0.214	<.001	4	view →
BLCA	All	All	−0.077	.024	3	view →
HNSC	Male	All	−0.049	.015	2	view →
COAD	All	II,III,IV	−0.025	.041	2	view →
LUAD	All	All	−0.128	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

FABP5P14–KIRC

Open the KIRC breakdown →